Mr. Speaker, I have constituents who have signed a petition calling on the government to recognize the importance of a pharmacare program, adding their voices to many others in terms of the need to look at the cost of pharmaceuticals that so many constituents are unable to afford. They are asking the government to look at that national pharmacare program and to work with the different stakeholders.
In the House of Commons on February 26th, 2018. See this statement in context.